Skip to main content

Table 3 Ectoparasiticide doses purchased by cat owners during a 12-month period

From: Analysis of gaps in feline ectoparasiticide purchases from veterinary clinics in the United States

Doses purchased per 12 months Fluralanera
(n = 27,138)
Fipronil /(s)-methoprene/ pyriproxyfen (n = 10,171) Imidacloprid/pyriproxyfen (n = 3480) Selamectin (n = 74,064)
1 18,265 (67.3%) 3609 (35.5%) 1903 (54.7%) 28,044 (37.9%)
2 5216 (19.2%) 1342 (13.2%) 467 (13.4%) 9202 (12.4%)
3 1986 (7.3%) 1846 (18.2%) 239 (6.9%) 8355 (11.3%)
4 1264 (4.7%) 963 (9.5%) 271 (7.8%) 2882 (3.9%)
5 407 (1.5%) 211 (2.1%) 67 (1.9%) 1392 (1.9%)
6   1045 (10.3%) 297 (8.5%) 12,160 (16.4%)
7   141 (1.4%) 37 (1.1%) 1584 (2.1%)
8   411 (4.0%) 94 (2.7%) 3118 (4.2%)
9   264 (2.6%) 16 (0.5%) 1595 (2.2%)
10   50 (0.5%) 12 (0.3%) 526 (0.7%)
11   38 (0.4%) 8 (0.2%) 361 (0.5%)
12   251 (2.5%)   4845 (6.5%)
  1. aBecause fluralaner topical has a 12-week dosing interval for most parasites on the product label, a maximum of 5 doses fluralaner topical purchases were considered for the 12-month period studied (Note: Up to 7 doses of fluralaner may be required for full year protection in areas where Dermacentor variabilis are of concern)